ADB’s Rapid COVID-19 Response in Southeast Asia

ADB has approved $5.813 billion in financing to help Southeast Asian countries cope with the devastating impacts of the pandemic. This support focuses on three key areas: boosting healthcare responses, enhancing social protection, and protecting businesses and economies. Recent assistance to Indonesia and the Philippines was also provided to support COVID-19 vaccine procurement and distribution under ADB’s Asia Pacific Vaccine Access Facility (APVAX).

The brochure provides details on how and where this assistance is being rolled out and includes country-specific examples. It also looks at ADB’s collaboration with the private sector and development partners, and the complementary support being provided through its knowledge and policy advice services.


This page was generated from /publications/adb-covid-19-response-southeast-asia on 04 April 2024

Source URL: